These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6259698)
1. Isomers of leukotriene B4 possess different biological potencies. Ford-Hutchinson AW; Bray MA; Cunningham FM; Davidson EM; Smith MJ Prostaglandins; 1981 Jan; 21(1):143-52. PubMed ID: 6259698 [TBL] [Abstract][Full Text] [Related]
2. The production and characterisation of products of the lipoxygenase enzyme system released by rat peritoneal macrophages. Doig MV; Ford-Hutchinson AW Prostaglandins; 1980 Dec; 20(6):1007-19. PubMed ID: 6259695 [TBL] [Abstract][Full Text] [Related]
3. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Ford-Hutchinson AW; Bray MA; Doig MV; Shipley ME; Smith MJ Nature; 1980 Jul; 286(5770):264-5. PubMed ID: 6250050 [TBL] [Abstract][Full Text] [Related]
4. Aggregation of polymorphonuclear leucocytes (PMNs) by leukotriene B4: effects of cyclooxygenase products and metabolic inhibitors. Cunningham FM; Carter HR; Smith MJ; Ford-Hutchinson AW; Bray MA Agents Actions; 1981 Dec; 11(6-7):583-4. PubMed ID: 6280463 [TBL] [Abstract][Full Text] [Related]
5. Biological activities of leukotriene B4. Smith MJ Agents Actions; 1981 Dec; 11(6-7):571-2. PubMed ID: 6280462 [TBL] [Abstract][Full Text] [Related]
6. Generation of leukotriene B4, its all trans isomers and 5-hydroxyeicosatetraenoic acid by rat basophilic leukaemia cells. Ford-Hutchinson AW; Piper PJ; Samhoun MN Br J Pharmacol; 1982 May; 76(1):215-20. PubMed ID: 6282374 [TBL] [Abstract][Full Text] [Related]
7. Leukotriene B4: a mediator of vascular permeability. Bray MA; Cunningham FM; Ford-Hutchinson AW; Smith MJ Br J Pharmacol; 1981 Mar; 72(3):483-6. PubMed ID: 6266567 [TBL] [Abstract][Full Text] [Related]
8. Leukotriene B4 is an incomplete agonist for the activation of human neutrophils. Prescott SM; Zimmerman GA; Seeger AR Biochem Biophys Res Commun; 1984 Jul; 122(2):535-41. PubMed ID: 6087805 [TBL] [Abstract][Full Text] [Related]
9. Arachidonic acid, leukotriene B4, and neutrophil activation. Naccache PH; Sha'afi RI Ann N Y Acad Sci; 1983; 414():125-39. PubMed ID: 6322649 [No Abstract] [Full Text] [Related]
10. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2. Movat HZ; Rettl C; Burrowes CE; Johnston MG Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579 [TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4: an inflammatory mediator with vascular actions in vivo. Bray MA Agents Actions Suppl; 1982; 11():51-61. PubMed ID: 6295113 [TBL] [Abstract][Full Text] [Related]
12. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid. Raulf M; König W Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420 [TBL] [Abstract][Full Text] [Related]
13. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400 [TBL] [Abstract][Full Text] [Related]
14. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Clancy RM; Dahinden CA; Hugli TE Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105 [TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4: biological activities and the cytoskeleton. Cunningham FM; Smith MJ Br J Pharmacol; 1982 Feb; 75(2):383-7. PubMed ID: 6313109 [TBL] [Abstract][Full Text] [Related]
17. Comparative biological activities of synthetic leukotriene B4 and its omega-oxidation products. Ford-Hutchinson AW; Rackham A; Zamboni R; Rokach J; Roy S Prostaglandins; 1983 Jan; 25(1):29-37. PubMed ID: 6302739 [No Abstract] [Full Text] [Related]
18. Tissue differences in vascular permeability induced by leukotriene B4 and prostaglandin E2 in the rat. Stenson WF; Chang K; Williamson JR Prostaglandins; 1986 Jul; 32(1):5-17. PubMed ID: 3020620 [TBL] [Abstract][Full Text] [Related]
19. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release. Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972 [TBL] [Abstract][Full Text] [Related]
20. A neutrophil-derived cytochrome P450-dependent metabolite of arachidonic acid modulates neutrophil behavior. Kraemer R; Bednar MM; Hatala MA; Mullane KM Am J Pathol; 1987 Sep; 128(3):446-54. PubMed ID: 2820233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]